Slide 1: Analyst and press conference
Analyst and press conference Zurich, 29 May 2015
Slide 2: Disclaimer
Disclaimer This communication contains statements that constitute “forward‐looking statements”. In this communication, such forward‐looking statements include, without limitation, statements relating to our financial condition, results of operations and business and certain of our strategic plans an
Slide 3: Speakers
Speakers Antoine • Delegate of the Board ‐ AEVIS Holding SA (AEVIS) Hubert Beat • CEO ‐ Genolier Swiss Medical Network SA (GSMN) Röthlisberger Christoph • CEO ‐ Swiss Healthcare Properties AG (SHP) Syz Beat • CEO ‐ Victoria‐Jungfrau Collection AG (VJC) Sigg ANALYST AND PRESS CONFERENCE I 3
Slide 4: Presentation of AEVIS Holding SA
Presentation of AEVIS Holding SA Antoine Hubert, Delegate of the Board ANALYST AND PRESS CONFERENCE I 4
Slide 5: AEVIS – value creation through acquisitions
AEVIS – value creation through acquisitions • Clinique de • Bethanien • Ars Medica • Valère • Montbrillant Montchoisi • OPA AEVIS • Sant’Anna • Providence • CMEV • New name • OPA VJC • Clinique de • Clinique • HDG • Lindberg AEVIS • Schmerzklinik Genolier Générale • Vente Agefi • Pyramide • SHP • Vi
Slide 6: Highlights and outlook
Highlights and outlook • Growth strategy of Genolier Swiss Medical Network SA (“GSMN”) successfully continued with the integration of the 15th clinic Strategic • Integration and growth strategy of Swiss Healthcare Properties AG (“SHP”) milestones progressing with the integration of the buildings of
Slide 7: AEVIS Annual Results 2014 – balance sheet
AEVIS Annual Results 2014 – balance sheet In CHF '000 31.12.2014 31.12.2013 Asset base in excess of CHF 1.28 billion thanks to the Cash and cash equivalents 48'574 29'065 acquisition of VJC and Villa im Other current assets 178'700 158'114 Total current assets 227'274 187'179 Park real estate Fixed
Slide 8: AEVIS Annual Results 2014 – income statement
AEVIS Annual Results 2014 – income statement In CHF '000 2014 2013 Strong revenue growth (+19.3%) through targeted acquisitions Revenue 542'372 454'669 growth 19.3% n.a. Slight decrease in EBITDA margin at 12.1%, due to the integration of Operating expenses (419'484) (341'697) EBITDA 65'403 60'755 n
Slide 9: AEVIS: Leading healthcare and hotel platform strategy
Leading healthcare and hotel platform strategy 2nd largest group • Nescens ‐ live better and longer GSMN of private clinics • AEVIS’ branding strategy in Switzerland to lever selected points of Nescens excellence both within GSMN Leading luxury and VJC, and AEVIS VJC hotel collection establish b
Slide 10: High visibility on capital markets
High visibility on capital markets AEVIS is listed on the Domestic Standard of SIX Swiss Exchange (Ticker: AEVS) • Stock price 27.05.2015: CHF 44.8 • 60d VWAP: CHF 44.90 • Current market cap: CHF 647.8 million To diversify its financing sources, AEVIS has successfully issued three straight bonds: •
Slide 11: Presentation of Genolier Swiss Medical Network SA
Presentation of Genolier Swiss Medical Network SA Beat Röthlisberger, CEO ANALYST AND PRESS CONFERENCE I 11
Slide 12: Genolier Swiss Medical Network SA (GSMN)
Genolier Swiss Medical Network SA (GSMN) • GSMN is the 2nd largest network of private clinics in Switzerland, present in all 3 linguistic regions Strong player in the private healthcare sector in Switzerland Reliable private alternative to the public healthcare system Leader for medical touris
Slide 13: Key achievements 2014
Key achievements 2014 • Continued growth strategy lead to the expansion of the clinics portfolio to 14 clinics by the end of 2014. Nearly 60 additional attending physicians joined GSMN • Launch of training and development program Genolier Academy General • Turnover of CHF 461.2 million, 6.3% above 2
Slide 14: Key projects 2015
Key projects 2015 Continued growth strategy with the integration of further clinics (Clinique Montbrillant early 2015) and the recruiting of new admitting physicians Focus on profitability with the optimisation of processes and uncovering of synergies • Increase and sustain market position and profi
Slide 15: Presentation of Swiss Healthcare Properties SA
Presentation of Swiss Healthcare Properties SA Christoph Syz, CEO ANALYST AND PRESS CONFERENCE I 15
Slide 16: Swiss Healthcare Properties AG (SHP)
Swiss Healthcare Properties AG (SHP) SHP portfolio key figures • SHP is a real estate company focusing on • Healthcare properties 28 (13 sites) investments in healthcare related properties all • Rental area 120’480m2 over Switzerland • Global plot area 189’897m2 • Today, SHP owns 28 healthcare prope
Slide 17: Key achievements 2014
Key achievements 2014 • Continued expansion of SHP’s portfolio from a valuation, surface and rental income perspective • Positioning of SHP as a specialized healthcare real‐estate investor further sharpened with the start of a tenant diversification strategy General • Rental income amounted to CHF 3
Slide 18: Key projects 2015
Key projects 2015 With 28 different properties across Switzerland and a vacancy rate of 0%, SHP expects a stable organic growth of rental income To further improve the portfolio targeted development projects are planned for 2015 and beyond • Villa im Park: Construction of a additional building as we
Slide 19: Presentation of Victoria-Jungfrau Collection AG
Presentation of Victoria‐Jungfrau Collection AG Beat Sigg, CEO ANALYST AND PRESS CONFERENCE I 19
Slide 20: Victoria-Jungfrau Collection AG (VJC)
Victoria‐Jungfrau Collection AG (VJC) • VJC is the leading luxury hotel group comprising four 5‐stars hotels in Swiss prime locations Zurich, Bern, Lucerne and Interlaken • AEVIS acquired 71.2% of VJC in April 2014 • The acquisition was a diversification move to consolidate AEVIS’ strategic focus on
Slide 21: Key achievements 2014
Key achievements 2014 • After a successful and friendly takeover process, the VJC is consolidated in AEVIS since 1 April 2014 as a new division • Integration process is advancing smoothly with a good cultural fit between the management teams of AEVIS and VJC General • Stronger occupancy rates throug
Slide 22: Key projects 2015
Key projects 2015 Ongoing optimization of the positioning of every hotel in order to be able to improve room and occupancy rates to continue organic growth Further integration into AEVIS and La Réserve / Seiler Hotels in order to maximise synergies for cost‐cuttings and marketing reach Negotiations
Slide 23: Presentation of NESCENS
Presentation of NESCENS Antoine Hubert, Delegate of the Board ANALYST AND PRESS CONFERENCE I 23
Slide 24: Nescens
Nescens • Nescens offers innovative products and services for a better living / better aging connecting healthcare, wellness and lifestyle under a Swiss high quality brand • Nescens is applied within GSMN’s clinics as well as within VJC’s and the other affiliated hotels • Integrated approach combini
Slide 25: Merger of AEVIS and VJC
Merger of AEVIS and VJC Antoine Hubert, Delegate of the Board of AEVIS Beat Sigg, Delegate of the Board of VJC ANALYST AND PRESS CONFERENCE I 25
Slide 26: Merger of VJC and AEVIS
Merger of VJC and AEVIS The boards of directors of AEVIS and VJC have concluded a contract regarding the merger of both companies As a result of this merger, AEVIS Holding SA will change its name to AEVIS VICTORIA SA VJC shareholders will receive 8 AEVIS shares per VJC share This merger, subject to
Slide 27: Valuation overview
Valuation overview The exchange ratio of 8 AEVIS shares per VJC share is based on a price per VJC share of CHF 359.20 and CHF 44.90 per AEVIS share (60d VWAP on 27 May 2015) The board of directors of VJC has mandated the independent valuation expert The Corporate Finance Group to establish a fairnes
Slide 28: Important information regarding the merger
Important information regarding the merger The merger is subject to the approval of the general assemblies of AEVIS and VJC The hotel activities of VJC will continue to be consolidated in a sub‐holding of AEVIS called Victoria‐Jungfrau Collection AG Management and board of directors of VJC will rema
Slide 29: Thank you for your interest – Q&A
Thank you for your interest Q&A ANALYST AND PRESS CONFERENCE I 29
Slide 30: Financial calendar
Financial calendar June 2015 Publication of 1Q2015 turnover 29 June 2015 Ordinary General Shareholders Meeting for the year 2014 30 September 2015 Half‐yearly results 1H2015 November 2015 Publication of 3Q2015 turnover March 2016 Publication of 2015 turnover 29 April 2016 Annual Results 2015 AEVIS H
Slide 31: AEVIS Holding
Alr\'S HOLDING